Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Alphamab Oncology Marks Milestone as First Patient Receives Dose in Australian Clinical Trial for Subcutaneous Formulation JSKN033

Tuesday, March 26, 2024

Alphamab Oncology has recently announced the commencement of dosing for the first patient in Australia for their clinical trial JSKN of JSKN This compound is a subcutaneous formulation

AriBio Secures Exclusive Marketing Rights for AR1001 to Address Alzheimer's Disease in China Through $770 Million Agreement

Monday, March 25, 2024

AriBio Co Ltd recently finalized a substantial contract for AR an investigational drug targeting earlystage Alzheimers disease in China amounting to up to million for exclusive marketing rights

NurExone Enters Agreement for Large-Scale Preclinical Testing of ExoPTEN, Advancing Spinal Cord Injury Therapy Toward Human Clinical Trials

Saturday, March 23, 2024

NurExone Biologic Inc a pioneering biopharmaceutical company specializing in regenerative medicine therapies has announced a strategic collaboration with Vivox Ltd

HUTCHMED Launches Registration Phase for Sovleplenib Trial Targeting Warm Antibody Autoimmune Hemolytic Anemia in China

Friday, March 22, 2024

HUTCHMED Limited made an announcement today regarding the initiation of the registration stage for the Phase IIIII clinical trial of sovleplenib in adult patients with warm antibody autoimmune

SK Bioscience Expands into Southern Hemisphere Vaccine Market with Influenza Vaccine Export to Thailand

Friday, March 22, 2024

SK bioscience a renowned global vaccine and biotech firm dedicated to advancing human health through prevention and treatment announced today that it has sent approximately doses of SKYCellflu

Scilex Holding Company Settles Patent Dispute with Takeda Pharmaceuticals Over Gloperba® Label Expansion

Thursday, March 21, 2024

Scilex Holding Company a company focused on acquiring developing and commercializing nonopioid pain management products for both acute and chronic pain

Senhwa Biosciences Starts Phase II Study of Silmitasertib for Community-Acquired Pneumonia with Viral Infection in Taiwan

Thursday, March 21, 2024

Senhwa Biosciences Inc a pharmaceutical company specializing in novel therapeutics for oncology rare diseases and infectious diseases has announced a significant milestone today

23andMe Launches Phase 1 Trial for 23ME-01473 Antibody Targeting ULBP6

Thursday, March 21, 2024

andMe Holding Co has announced the initiation of a Phase clinical trial for ME targeting advanced solid tumors This trial marks a significant milestone as the first participant receives dosing The investigational antibody ULBP targeted by was disco...

Everest Medicines Receives Approval from Singapore Health Sciences Authority for NEFEGAN® in Treating Primary IgA Nephropathy Among Adult Patients

Wednesday, March 20, 2024

Everest Medicines a biopharmaceutical company focused on developing innovative medicines and vaccines has announced that the Singapore Health Sciences Authority

Bill & Melinda Gates Medical Research Institute Launches Phase 3 Trial for Tuberculosis Vaccine Candidate

Wednesday, March 20, 2024

The Bill Melinda Gates Medical Research Institute has announced the commencement of a Phase clinical trial to evaluate the effectiveness of the MASE tuberculosis